Corcept’s cancer drug meets main goal in late-stage trial
By Thomson ReutersJan 22, 2026 | 7:11 AM
Jan 22 (Reuters) – Corcept Therapeutics said on Thursday that its experimental cancer drug met the main goal in a late-stage study.
(Reporting by Sahil Pandey in Bengaluru; Editing by Shailesh Kuber)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.
